CROCHEMORE, CHRISTOPHE
 Distribuzione geografica
Continente #
NA - Nord America 216
EU - Europa 125
AS - Asia 41
AF - Africa 18
Totale 400
Nazione #
US - Stati Uniti d'America 216
GB - Regno Unito 30
SE - Svezia 23
CN - Cina 19
DE - Germania 16
UA - Ucraina 15
IT - Italia 14
SG - Singapore 14
IE - Irlanda 5
IN - India 5
NG - Nigeria 5
RU - Federazione Russa 5
CI - Costa d'Avorio 4
FR - Francia 4
TG - Togo 4
BE - Belgio 3
EE - Estonia 3
ZA - Sudafrica 3
ES - Italia 2
FI - Finlandia 2
JO - Giordania 2
SC - Seychelles 2
CH - Svizzera 1
GR - Grecia 1
HK - Hong Kong 1
NL - Olanda 1
Totale 400
Città #
Southend 27
Houston 25
Fairfield 23
Ashburn 22
Chandler 18
Woodbridge 16
Ann Arbor 15
Seattle 14
Singapore 13
Jacksonville 12
Wilmington 10
Santa Clara 8
Cambridge 6
Princeton 6
Boardman 5
Dublin 5
Abidjan 4
Lomé 4
Abeokuta 3
Beijing 3
Berlin 3
Bologna 3
Brussels 3
Des Moines 3
Padova 3
Westminster 3
Amman 2
Helsinki 2
Mahé 2
Mülheim 2
Nanjing 2
Palermo 2
Saint Petersburg 2
Baoding 1
Bern 1
Bremen 1
Bühl 1
Cedar Knolls 1
Central 1
Changsha 1
Chicago 1
Falkenstein 1
Groningen 1
Hangzhou 1
Hebei 1
Jinan 1
Lagos 1
Milan 1
Ningbo 1
Olalla 1
Plauen 1
San Diego 1
Shenyang 1
Shenzhen 1
Verona 1
Washington 1
Xi'an 1
Totale 295
Nome #
Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model froamyotrophic lateral sclerosis 155
Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural origin. 147
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 104
Totale 406
Categoria #
all - tutte 957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 24 13 13 13 7 5 4
2020/202146 10 3 3 2 1 8 0 3 3 4 4 5
2021/202260 7 1 6 7 3 6 0 2 2 6 11 9
2022/202383 5 11 6 11 6 9 1 4 18 4 3 5
2023/202417 0 5 1 1 1 5 0 1 0 1 0 2
2024/202545 4 11 4 7 11 8 0 0 0 0 0 0
Totale 406